Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 1
2006 5
2008 3
2009 2
2010 1
2011 6
2012 4
2013 4
2015 3
2016 5
2017 2
2018 3
2019 5
2020 5
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.
Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, Invitti C, Litwin M, Mancia G, Pall D, Rascher W, Redon J, Schaefer F, Seeman T, Sinha M, Stabouli S, Webb NJ, Wühl E, Zanchetti A. Lurbe E, et al. Among authors: invitti c. J Hypertens. 2016 Oct;34(10):1887-920. doi: 10.1097/HJH.0000000000001039. J Hypertens. 2016. PMID: 27467768
A High Protein Diet Is More Effective in Improving Insulin Resistance and Glycemic Variability Compared to a Mediterranean Diet-A Cross-Over Controlled Inpatient Dietary Study.
Tettamanzi F, Bagnardi V, Louca P, Nogal A, Monti GS, Mambrini SP, Lucchetti E, Maestrini S, Mazza S, Rodriguez-Mateos A, Scacchi M, Valdes AM, Invitti C, Menni C. Tettamanzi F, et al. Among authors: invitti c. Nutrients. 2021 Dec 7;13(12):4380. doi: 10.3390/nu13124380. Nutrients. 2021. PMID: 34959931 Free PMC article. Clinical Trial.
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention.
Baldassarre D, Iacoviello L, Baetta R, Roncaglioni MC, Condorelli G, Remuzzi G, Gensini G, Frati L, Ricciardi W, Conaldi PG, Uccelli A, Blandini F, Bosari S, Scambia G, Fini M, Di Malta A, Amato M, Veglia F, Bonomi A, Klersy C, Colazzo F, Pengo M, Gorini F, Auteri L, Ferrante G, Baviera M, Ambrosio G, Catapano A, Gialluisi A, Malavazos AE, Castelvecchio S, Corsi-Romanelli MM, Cardani R, La Rovere MT, Agnese V, Pane B, Prati D, Spinardi L, Liuzzo G, Arbustini E, Volterrani M, Visconti M, Werba JP, Genovese S, Bilo G, Invitti C, Di Blasio A, Lombardi C, Faini A, Rosa D, Ojeda-Fernández L, Foresta A, De Curtis A, Di Castelnuovo A, Scalvini S, Pierobon A, Gorini A, Valenti L, Luzi L, Racca A, Bandi M, Tremoli E, Menicanti L, Parati G, Pompilio G; CV-PREVITAL Study Group. Baldassarre D, et al. Among authors: invitti c. BMJ Open. 2023 Jul 14;13(7):e072040. doi: 10.1136/bmjopen-2023-072040. BMJ Open. 2023. PMID: 37451717 Free PMC article. Clinical Trial.
Can glycaemia affect blood pressure?
Invitti C. Invitti C. J Hypertens. 2003 Jul;21(7):1265-7. doi: 10.1097/00004872-200307000-00012. J Hypertens. 2003. PMID: 12817171 Review. No abstract available.
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus.
Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, Dauriz M, Dotta F, Formichi C, Frontoni S, Invitti C, Orsi E, Picconi F, Resi V, Bonora E, Purrello F. Sesti G, et al. Among authors: invitti c. Acta Diabetol. 2019 Jun;56(6):605-617. doi: 10.1007/s00592-018-1271-3. Epub 2019 Jan 2. Acta Diabetol. 2019. PMID: 30603867 Review.
Metabolic endotoxaemia in childhood obesity.
Varma MC, Kusminski CM, Azharian S, Gilardini L, Kumar S, Invitti C, McTernan PG. Varma MC, et al. Among authors: invitti c. BMC Obes. 2016 Jan 27;3:3. doi: 10.1186/s40608-016-0083-7. eCollection 2015. BMC Obes. 2016. PMID: 26819711 Free PMC article.
51 results